Trial intelligence / Profile preview

Trikafta in Non-cystic Fibrosis Bronchiectasis

NCT05743946Phase 4Completed

Sponsor
Emory University
Start
Apr 2023
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of elexacaftor + tezacaftor + ivacaftor in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Emory University. Started Apr 2023; status: completed.

02

Drugs

elexacaftor + tezacaftor + ivacaftor
03

Conditions

Non-cystic fibrosis bronchiectasis (NCFB)

Beyond the preview

Go deeper on NCT05743946.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05743946.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call